Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications

M Barbot, M Zilio, C Scaroni - … practice & research Clinical endocrinology & …, 2020 - Elsevier
Cushing's syndrome (CS) is a severe condition that results from chronic exposure to
elevated circulating cortisol levels; it is a rare but potentially life-threating condition …

Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome: a systematic meta-analysis

J Wagner, F Langlois, DST Lim, S McCartney… - Frontiers in …, 2019 - frontiersin.org
Background: Hypercortisolism has been implicated in the development of venous
thromboembolic events (VTE). We aimed to characterize VTE risk in endogenous Cushing's …

Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer: American College of Chest …

DE Ost, SCJ Yeung, LT Tanoue, MK Gould - Chest, 2013 - Elsevier
Background This guideline is intended to provide an evidence-based approach to the initial
evaluation of patients with known or suspected lung cancer. It also includes an assessment …

Hypercoagulability in C ushing's syndrome: prevalence, pathogenesis and treatment

R van der Pas, FWG Leebeek, LJ Hofland… - Clinical …, 2013 - Wiley Online Library
Cushing's syndrome is not only accompanied by an increased prevalence of cardiovascular
disease but also by a hypercoagulable state that is reflected by an increased incidence of …

Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience

S Ejaz, R Vassilopoulou‐Sellin, NL Busaidy, MI Hu… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Cushing syndrome (CS) secondary to ectopic adrenocorticotropic hormone
(ACTH) secretion (EAS) has been described in association with a variety of tumors. The …

Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect

AM Isidori, M Minnetti, E Sbardella… - European journal of …, 2015 - academic.oup.com
Glucocorticoids (GCs) target several components of the integrated system that preserves
vascular integrity and free blood flow. Cohort studies on Cushing's syndrome (CS) have …

[HTML][HTML] Paraneoplastic syndromes in small cell lung cancer

Z Soomro, M Youssef, S Yust-Katz, A Jalali… - Journal of Thoracic …, 2020 - ncbi.nlm.nih.gov
Paraneoplastic syndromes can commonly occur due to lung cancer, especially small cell
lung cancer. Frequently paraneoplastic syndromes can precede the diagnosis of the …

Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after …

L Manetti, F Bogazzi, C Giovannetti… - European Journal of …, 2010 - academic.oup.com
Objectives To evaluate whether patients with Cushing's syndrome (CS) had i) changes in
coagulative and fibrinolytic parameters associated with CS activity and ii) higher prevalence …

Adverse effects of glucocorticoids: coagulopathy

MCA Coelho, CV Santos, LV Neto… - European Journal of …, 2015 - academic.oup.com
Hypercortisolism is associated with various systemic manifestations, including central
obesity, arterial hypertension, glucose intolerance/diabetes mellitus, dyslipidemia …

Management of endocrine disease: cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach

EV Varlamov, F Langlois, G Vila… - European journal of …, 2021 - academic.oup.com
Cushing's syndrome (CS) is associated with increased mortality that is driven by
cardiovascular, thromboembolic, and infection complications. Although these events are …